Sartar Therapeutics closed 2.3 million euro crowdfunding round
A pharmaceutical company Sartar Therapeutics, a SPARK Finland alumni, has closed a crowdfunding campaign with great success. Funding round was organized by Springvest and campaign opened in October 14th at 11.30. Amazingly the maximum amount 2.3 million euro was reached already by today (October 19) at 16.17.
You can find the campaign page at https://app.springvest.fi/rounds/144?locale=en
SPARK Finland congratulates Harri Sihto, whole Sartar team, and Springvest for a great success in funding round!